NeuroMetrix, Inc. (NURO)의 가격은 얼마입니까?

NeuroMetrix, Inc. (NURO)의 가격은 $4.58입니다.

NeuroMetrix, Inc. (NURO)의 시가 총액은 무엇입니까?

NeuroMetrix, Inc. (NURO)의 시가 총액은 $6.98M입니다.

NeuroMetrix, Inc. (NURO) 배당금

NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.

연도	배당금 (주식 분할 조정됨)	변화
2026 (TTM)	$13,824.00	0.00%
2007	$13,824.00	0.00%

연도

배당금 (주식 분할 조정됨)

변화

2026 (TTM)

$13,824.00

0.00%

2007

$13,824.00

0.00%

연도	배당금	변화
2026 (TTM)	$0.15	0.00%
2007	$0.15	0.00%

연도

배당금

변화

2026 (TTM)

$0.15

0.00%

2007

$0.15

0.00%

회사	배당 지급 횟수	국가
Abbott Laboratories ABT.US	173.00%	US
Stryker Corporation SYK.US	85.00%	US
Medtronic plc MDT.US	178.00%	IE
Boston Scientific Corporation BSX.US	0.00%	US
Edwards Lifesciences Corporation EW.US	0.00%	US

회사

배당 지급 횟수

국가